Oct 2018 – Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global interest in recent years. DL has been widely adopted in image recognition, speech recognition and natural language processing, but is only beginning to impact on healthcare. In ophthalmology, DL has been applied to fundus photographs, optical coherence tomography and visual fields.
The paper discusses the robust performance in the detection of diabetic retinopathy and retinopathy of prematurity, the glaucoma-like disc, macular oedema and age-related macular degeneration. DL in ocular imaging may be used in conjunction with telemedicine as a possible solution to screen, diagnose and monitor major eye diseases for patients in primary care and community settings.
The authors also highlighted potential challenges with DL application in ophthalmology, including clinical and technical challenges, explainability of the algorithm results, medico-legal issues, and physician and patient acceptance of the AI ‘black-box’ algorithms.
DL could potentially revolutionise how ophthalmology is practised in the future. This review provides a summary of the state-of-the-art DL systems described for ophthalmic applications, potential challenges in clinical deployment and the path forward.
This article was originally published on ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, Volume 103, Issue 2 in Oct 2018 and can be read at: